1	Clinical	Clinical	B-NP	JJ	O	2	NMOD	-1
2	significance	significance	I-NP	NN	O	0	ROOT	-1
3	of	of	B-PP	IN	O	2	NMOD	-1
4	chicken	chicken	B-NP	NN	B-protein	8	NMOD	-1
5	ovalbumin	ovalbumin	I-NP	NN	I-protein	8	NMOD	-1
6	upstream	upstream	I-NP	JJ	I-protein	8	NMOD	-1
7	promoter-transcription	promoter-transcription	I-NP	NN	I-protein	8	NMOD	-1
8	factor	factor	I-NP	NN	I-protein	10	NMOD	-1
9	II	II	I-NP	CD	I-protein	8	NMOD	-1
10	expression	expression	I-NP	NN	O	3	PMOD	9	expression
11	in	in	B-PP	IN	O	10	NMOD	-1
12	human	human	B-NP	JJ	O	14	NMOD	-1
13	colorectal	colorectal	I-NP	JJ	O	14	NMOD	-1
14	cancer	cancer	I-NP	NN	O	11	PMOD	-1
15	.	.	O	.	O	2	P	-1

1	Chicken	Chicken	B-NP	NN	B-protein	5	NMOD	-1
2	ovalbumin	ovalbumin	I-NP	NN	I-protein	5	NMOD	-1
3	upstream	upstream	I-NP	JJ	I-protein	5	NMOD	-1
4	promoter-transcription	promoter-transcription	I-NP	NN	I-protein	5	NMOD	-1
5	factor	factor	I-NP	NN	I-protein	10	SUB	-1
6	II	II	I-NP	CD	I-protein	5	NMOD	-1
7	(	(	O	(	O	9	DEP	-1
8	COUP-TFII	COUP-TFII	B-NP	NN	O	9	DEP	-1
9	)	)	O	)	O	5	NMOD	-1
10	plays	play	B-VP	VBZ	O	0	ROOT	-1
11	an	an	B-NP	DT	O	13	NMOD	-1
12	essential	essential	I-NP	JJ	O	13	NMOD	0
13	role	role	I-NP	NN	O	10	OBJ	0
14	in	in	B-PP	IN	O	10	VMOD	-1
15	angiogenesis	angiogenesis	B-NP	NN	O	17	NMOD	3	angiogenesis
16	and	and	I-NP	CC	O	17	NMOD	-1
17	development	development	I-NP	NN	O	14	PMOD	0
18	.	.	O	.	O	10	P	-1

1	A	A	B-NP	DT	O	3	NMOD	-1
2	previous	previous	I-NP	JJ	O	3	NMOD	-1
3	study	study	I-NP	NN	O	4	SUB	-1
4	showed	show	B-VP	VBD	O	0	ROOT	-1
5	that	that	B-SBAR	IN	O	4	VMOD	-1
6	the	the	B-NP	DT	O	7	NMOD	-1
7	expression	expression	I-NP	NN	O	10	SUB	9	expression
8	of	of	B-PP	IN	O	7	NMOD	-1
9	COUP-TFII	COUP-TFII	B-NP	NN	B-protein	8	PMOD	-1
10	enhanced	enhance	B-VP	VBD	O	5	SBAR	17	enhanced
11	invasiveness	invasiveness	B-NP	NN	O	10	OBJ	14	invasiveness
12	of	of	B-PP	IN	O	11	NMOD	-1
13	human	human	B-NP	JJ	B-cell_type	16	NMOD	-1
14	lung	lung	I-NP	NN	I-cell_type	16	NMOD	-1
15	carcinoma	carcinoma	I-NP	NN	I-cell_type	16	NMOD	-1
16	cells	cell	I-NP	NNS	I-cell_type	12	PMOD	-1
17	.	.	O	.	O	4	P	-1

1	However	However	B-ADVP	RB	O	6	VMOD	-1
2	,	,	O	,	O	6	P	-1
3	no	no	B-NP	DT	O	5	NMOD	-1
4	published	publish	I-NP	VBN	O	5	NMOD	-1
5	data	datum	I-NP	NNS	O	6	SUB	-1
6	are	be	B-VP	VBP	O	0	ROOT	-1
7	available	available	B-ADJP	JJ	O	6	PRD	-1
8	concerning	concern	B-VP	VBG	O	7	AMOD	-1
9	the	the	B-NP	DT	O	13	NMOD	-1
10	biological	biological	I-NP	JJ	O	12	AMOD	-1
11	and	and	I-NP	CC	O	12	AMOD	-1
12	clinical	clinical	I-NP	JJ	O	13	NMOD	-1
13	significance	significance	I-NP	NN	O	8	OBJ	-1
14	of	of	B-PP	IN	O	13	NMOD	-1
15	COUP-TFII	COUP-TFII	B-NP	NN	B-protein	16	NMOD	-1
16	expression	expression	I-NP	NN	O	14	PMOD	9	expression
17	in	in	B-PP	IN	O	13	NMOD	-1
18	colorectal	colorectal	B-NP	JJ	O	19	NMOD	-1
19	cancer	cancer	I-NP	NN	O	17	PMOD	-1
20	.	.	O	.	O	6	P	-1

1	Thus	Thus	B-ADVP	RB	O	5	VMOD	-1
2	,	,	O	,	O	5	P	-1
3	our	our	B-NP	PRP$	O	4	NMOD	-1
4	objective	objective	I-NP	NN	O	5	SUB	-1
5	was	be	B-VP	VBD	O	0	ROOT	-1
6	to	to	B-VP	TO	O	7	VMOD	-1
7	explore	explore	I-VP	VB	O	5	PRD	-1
8	the	the	B-NP	DT	O	9	NMOD	-1
9	expression	expression	I-NP	NN	O	7	OBJ	9	expression
10	of	of	B-PP	IN	O	9	NMOD	-1
11	COUP-TFII	COUP-TFII	B-NP	NN	B-protein	10	PMOD	-1
12	in	in	B-PP	IN	O	9	NMOD	-1
13	colorectal	colorectal	B-NP	JJ	O	14	NMOD	-1
14	cancer	cancer	I-NP	NN	O	12	PMOD	-1
15	as	as	B-CONJP	RB	O	12	PMOD	-1
16	well	well	I-CONJP	RB	O	15	DEP	-1
17	as	as	I-CONJP	IN	O	15	DEP	-1
18	its	its	B-NP	PRP$	O	19	NMOD	-1
19	association	association	I-NP	NN	O	12	PMOD	0
20	with	with	B-PP	IN	O	19	NMOD	-1
21	clinicopathological	clinicopathological	B-NP	JJ	O	22	NMOD	-1
22	features	feature	I-NP	NNS	O	20	PMOD	-1
23	,	,	O	,	O	7	P	-1
24	and	and	O	CC	O	7	VMOD	-1
25	to	to	B-VP	TO	O	26	VMOD	-1
26	evaluate	evaluate	I-VP	VB	O	7	VMOD	-1
27	the	the	B-NP	DT	O	28	NMOD	-1
28	role	role	I-NP	NN	O	26	OBJ	16	role
29	of	of	B-PP	IN	O	28	NMOD	-1
30	COUP-TFII	COUP-TFII	B-NP	NN	B-protein	29	PMOD	-1
31	as	as	B-PP	IN	O	28	NMOD	-1
32	a	a	B-NP	DT	O	34	NMOD	-1
33	prognostic	prognostic	I-NP	JJ	O	34	NMOD	-1
34	indicator	indicator	I-NP	NN	O	31	PMOD	-1
35	in	in	B-PP	IN	O	34	NMOD	-1
36	colorectal	colorectal	B-NP	JJ	O	37	NMOD	-1
37	cancer	cancer	I-NP	NN	O	35	PMOD	-1
38	.	.	O	.	O	5	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	investigated	investigate	B-VP	VBD	O	0	ROOT	-1
3	the	the	B-NP	DT	O	4	NMOD	-1
4	presence	presence	I-NP	NN	O	15	NMOD	14	presence
5	of	of	B-PP	IN	O	4	NMOD	-1
6	COUP-TFII	COUP-TFII	B-NP	NN	B-protein	5	PMOD	-1
7	in	in	B-PP	IN	O	4	NMOD	-1
8	human	human	B-NP	JJ	O	11	NMOD	-1
9	colorectal	colorectal	I-NP	JJ	O	11	NMOD	-1
10	cancer	cancer	I-NP	NN	O	11	NMOD	-1
11	tissues	tissue	I-NP	NNS	O	7	PMOD	-1
12	and	and	O	CC	O	15	NMOD	-1
13	adjacent	adjacent	B-NP	JJ	O	15	NMOD	-1
14	normal	normal	I-NP	JJ	O	15	NMOD	-1
15	tissues	tissue	I-NP	NNS	O	2	OBJ	-1
16	from	from	B-PP	IN	O	15	NMOD	-1
17	95	95	B-NP	CD	O	21	NMOD	-1
18	primary	primary	I-NP	JJ	O	21	NMOD	-1
19	colorectal	colorectal	I-NP	JJ	O	21	NMOD	-1
20	cancer	cancer	I-NP	NN	O	21	NMOD	-1
21	patients	patient	I-NP	NNS	O	16	PMOD	-1
22	by	by	B-PP	IN	O	2	VMOD	-1
23	immunohistochemistry	immunohistochemistry	B-NP	NN	O	22	PMOD	-1
24	.	.	O	.	O	2	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	correlation	correlation	I-NP	NN	O	11	SUB	-1
3	between	between	B-PP	IN	O	2	NMOD	-1
4	the	the	B-NP	DT	O	5	NMOD	-1
5	expression	expression	I-NP	NN	O	3	PMOD	9	expression
6	of	of	B-PP	IN	O	5	NMOD	-1
7	COUP-TFII	COUP-TFII	B-NP	NN	B-protein	10	NMOD	-1
8	and	and	O	CC	O	10	NMOD	-1
9	clinicopathologic	clinicopathologic	B-NP	JJ	O	10	NMOD	-1
10	features	feature	I-NP	NNS	O	6	PMOD	-1
11	was	be	B-VP	VBD	O	0	ROOT	-1
12	investigated	investigate	I-VP	VBN	O	11	VC	-1
13	.	.	O	.	O	11	P	-1

1	The	The	B-NP	DT	O	4	NMOD	-1
2	3-year	3-year	I-NP	JJ	O	4	NMOD	-1
3	disease-free	disease-free	I-NP	JJ	O	4	NMOD	-1
4	survival	survival	I-NP	NN	O	10	NMOD	0
5	(	(	O	(	O	7	DEP	-1
6	DFS	DFS	B-NP	NN	B-protein	7	DEP	-1
7	)	)	O	)	O	4	NMOD	-1
8	and	and	O	CC	O	10	NMOD	-1
9	overall	overall	B-NP	JJ	O	10	NMOD	-1
10	survival	survival	I-NP	NN	O	23	SUB	0
11	(	(	O	(	O	13	DEP	-1
12	OS	OS	B-NP	NN	O	13	DEP	-1
13	)	)	O	)	O	10	NMOD	-1
14	of	of	B-PP	IN	O	10	NMOD	-1
15	patients	patient	B-NP	NNS	O	14	PMOD	-1
16	with	with	B-PP	IN	O	15	NMOD	-1
17	tumors	tumor	B-NP	NNS	O	16	PMOD	-1
18	expressing	express	B-VP	VBG	O	17	NMOD	9	expressing
19	different	different	B-NP	JJ	O	20	NMOD	-1
20	levels	level	I-NP	NNS	O	18	OBJ	-1
21	of	of	B-PP	IN	O	20	NMOD	-1
22	COUP-TFII	COUP-TFII	B-NP	NN	B-protein	21	PMOD	-1
23	were	be	B-VP	VBD	O	0	ROOT	-1
24	evaluated	evaluate	I-VP	VBN	O	23	VC	-1
25	by	by	B-PP	IN	O	24	VMOD	-1
26	the	the	B-NP	DT	O	28	NMOD	-1
27	Kaplan-Meier	Kaplan-Meier	I-NP	NNP	O	28	NMOD	-1
28	method	method	I-NP	NN	O	25	PMOD	-1
29	.	.	O	.	O	23	P	-1

1	No	No	B-NP	DT	O	3	NMOD	-1
2	significant	significant	I-NP	JJ	O	3	NMOD	-1
3	correlation	correlation	I-NP	NN	O	4	SUB	-1
4	was	be	B-VP	VBD	O	0	ROOT	-1
5	found	find	I-VP	VBN	O	4	VC	0
6	between	between	B-PP	IN	O	30	NMOD	-1
7	COUP-TFII	COUP-TFII	B-NP	NN	B-protein	8	NMOD	-1
8	expression	expression	I-NP	NN	O	10	NMOD	9	expression
9	and	and	O	CC	O	10	NMOD	-1
10	age	age	B-NP	NN	O	6	PMOD	-1
11	at	at	B-PP	IN	O	10	NMOD	-1
12	surgery	surgery	B-NP	NN	O	23	NMOD	0
13	,	,	O	,	O	23	P	-1
14	gender	gender	B-NP	NN	O	23	NMOD	-1
15	,	,	O	,	O	23	P	-1
16	histopathologic	histopathologic	B-NP	JJ	O	17	NMOD	-1
17	differentiation	differentiation	I-NP	NN	O	23	NMOD	0
18	,	,	O	,	O	23	P	-1
19	vessel	vessel	B-NP	NN	O	20	NMOD	-1
20	invasion	invasion	I-NP	NN	O	23	NMOD	14	invasion
21	,	,	O	,	O	23	P	-1
22	carcinoembryonic	carcinoembryonic	B-NP	JJ	B-protein	23	NMOD	-1
23	antigen	antigen	I-NP	NN	I-protein	11	PMOD	-1
24	(	(	O	(	O	26	DEP	-1
25	CEA	CEA	B-NP	NN	B-protein	26	DEP	-1
26	)	)	O	)	O	23	NMOD	-1
27	,	,	O	,	O	30	P	-1
28	or	or	O	CC	O	30	NMOD	-1
29	nodal	nodal	B-NP	JJ	O	30	NMOD	-1
30	involvement	involvement	I-NP	NN	O	5	VMOD	0
31	.	.	O	.	O	4	P	-1

1	However	However	B-ADVP	RB	O	5	VMOD	-1
2	,	,	O	,	O	5	P	-1
3	survival	survival	B-NP	NN	O	4	NMOD	0
4	analysis	analysis	I-NP	NN	O	5	SUB	-1
5	showed	show	B-VP	VBD	O	0	ROOT	-1
6	that	that	B-SBAR	IN	O	5	VMOD	-1
7	the	the	B-NP	DT	O	9	NMOD	-1
8	COUP-TFII-positive	COUP-TFII-positive	I-NP	JJ	O	9	NMOD	9	positive
9	group	group	I-NP	NN	O	10	SUB	-1
10	had	have	B-VP	VBD	O	6	SBAR	-1
11	a	a	B-NP	DT	O	14	NMOD	-1
12	significantly	significantly	I-NP	RB	O	13	AMOD	-1
13	better	good	I-NP	JJR	O	14	NMOD	-1
14	OS	OS	I-NP	NN	O	10	OBJ	-1
15	compared	compare	B-VP	VBN	O	10	VMOD	-1
16	to	to	B-PP	TO	O	15	PMOD	-1
17	COUP-TFII-negative	COUP-TFII-negative	B-NP	JJ	O	18	NMOD	9	negative
18	group	group	I-NP	NN	O	16	PMOD	-1
19	(	(	O	(	O	18	NMOD	-1
20	80.4	80.4	B-NP	CD	O	21	NMOD	-1
21	%	%	I-NP	NN	O	19	ROOT	-1
22	vs.	vs.	B-PP	IN	O	21	NMOD	-1
23	57.7	57.7	B-NP	CD	O	24	NMOD	-1
24	%	%	I-NP	NN	O	26	NMOD	-1
25	,	,	O	,	O	26	P	-1
26	P=0.0491	P=0.0491	B-NP	NN	O	22	PMOD	-1
27	)	)	O	)	O	26	NMOD	-1
28	.	.	O	.	O	21	P	-1

1	Based	Base	B-PP	VBN	O	7	VMOD	-1
2	on	on	B-PP	IN	O	1	PMOD	-1
3	our	our	B-NP	PRP$	O	4	NMOD	-1
4	results	result	I-NP	NNS	O	2	PMOD	0
5	,	,	O	,	O	7	P	-1
6	COUP-TFII	COUP-TFII	B-NP	NN	B-protein	7	SUB	-1
7	may	may	B-VP	MD	O	0	ROOT	-1
8	represent	represent	I-VP	VB	O	7	VC	-1
9	a	a	B-NP	DT	O	10	NMOD	-1
10	biomarker	biomarker	I-NP	NN	O	8	OBJ	-1
11	for	for	B-PP	IN	O	10	NMOD	-1
12	good	good	B-NP	JJ	O	13	NMOD	-1
13	prognosis	prognosis	I-NP	NN	O	11	PMOD	-1
14	in	in	B-PP	IN	O	10	NMOD	-1
15	colorectal	colorectal	B-NP	JJ	O	16	NMOD	-1
16	cancer	cancer	I-NP	NN	O	14	PMOD	-1
17	.	.	O	.	O	7	P	-1

